https://comparerx.org/news/adolescent-glp1-nutritional-deficiency-telehealth-safety CompareRx.org en 2026-09-29T20:15:28.483Z Teens on GLP-1s face 17% nutritional deficiency rate — the hidden risk of budget telehealth plans https://comparerx.org/news/roche-halts-early-stage-obesity-drug-emugrobart CompareRx.org en 2026-09-29T16:15:26.568Z Roche halts early-stage obesity drug emugrobart — narrowing options for US GLP-1 buyers https://comparerx.org/news/novo-nordisk-glp1-marketing-lifestyle-branding-telehealth CompareRx.org en 2026-09-29T12:15:27.271Z Novo shifts GLP-1 marketing to lifestyle branding — what it changes for telehealth buyers https://comparerx.org/news/cvs-survey-employers-overhaul-glp1-benefits-cash-telehealth CompareRx.org en 2026-09-29T08:15:28.657Z CVS survey reveals employers overhaul GLP-1 benefits — driving buyers to cash telehealth https://comparerx.org/news/glp1-marketing-lifestyle-brands-telehealth-buyers CompareRx.org en 2026-09-28T12:15:27.882Z GLP-1 marketing shifts to lifestyle branding — what it changes for telehealth buyers